<DOC>
	<DOCNO>NCT02497924</DOCNO>
	<brief_summary>This study provide information regard metabolic pathway GBT440 , need evaluation potential drug-drug interaction , need study special population . The administration radiolabeled drug necessary fully characterize rate route elimination GBT440 , provide quantitative information disposition GBT440 . The result study permit comprehensive comparison animal human route elimination metabolic profile GBT440 .</brief_summary>
	<brief_title>A Study Absorption , Metabolism , Excretion GBT440 Healthy Male Subjects</brief_title>
	<detailed_description />
	<mesh_term>Anemia , Sickle Cell</mesh_term>
	<criteria>1 . Healthy ; nonsmoking male ; 18 55 year old , inclusive 2 . Weighs least 50 kg 110 kg 3 . Agrees use contraception 4 . Willing able give write informed consent 1 . Evidence history clinically significant metabolic , allergic , dermatological , hepatic , renal , hematological , pulmonary , cardiovascular , gastrointestinal , neurological , psychiatric disorder 2 . History stomach intestinal surgery would potentially alter drug absorption 3 . History hypersensitivity allergy drug , food , substance 4 . History presence abnormal electrocardiogram 5 . Exposure significant radiation participate 1 radiolabeled study drug trial within 12 month Screening 6 . Participated another clinical trial investigational drug within 30 day ( 5 halflives investigational drug , whichever long ) prior Screening</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>September 2015</verification_date>
</DOC>